These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 3316278)
1. Effect of cyclosporin A treatment on the production of antibody in insulin-dependent (type I) diabetic patients. Boitard C; Feutren G; Castano L; Debray-Sachs M; Assan R; Hors J; Bach JF J Clin Invest; 1987 Dec; 80(6):1607-12. PubMed ID: 3316278 [TBL] [Abstract][Full Text] [Related]
2. [Detection of antibodies against pancreatic islet cells in clinical practice]. Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715 [TBL] [Abstract][Full Text] [Related]
3. Immune islet killing mechanisms associated with insulin-dependent diabetes: in vitro expression of cellular and antibody-mediated islet cell cytotoxicity in humans. Charles MA; Suzuki M; Waldeck N; Dodson LE; Slater L; Ong K; Kershnar A; Buckingham B; Golden M J Immunol; 1983 Mar; 130(3):1189-94. PubMed ID: 6337213 [TBL] [Abstract][Full Text] [Related]
4. [Immunosuppression with cyclosporin induces clinical remission and improved beta cell function in patients with newly diagnosed insulin-dependent diabetes. A national and international multicenter study]. Mandrup-Poulsen TR; Mølvig JC; Andersen V; Bendtzen K; Binder C; Brøns M; d'Amore FA; Dieperink H; Enk B; Frandsen NE Ugeskr Laeger; 1990 Jul; 152(27):1963-9. PubMed ID: 2195734 [TBL] [Abstract][Full Text] [Related]
5. Relation between cellular and humoral immunity to islet cell antigens in type 1 diabetes. Hummel M; Durinovic-Bello I; Ziegler AG J Autoimmun; 1996 Jun; 9(3):427-30. PubMed ID: 8816982 [TBL] [Abstract][Full Text] [Related]
6. The evaluation of thyroid and islet autoantibodies in type 1 diabetes mellitus. Prázný M; Skrha J; Límanová Z; Hilgertová J Sb Lek; 1999; 100(3):205-11. PubMed ID: 11221467 [TBL] [Abstract][Full Text] [Related]
7. Course of islet autoantibody titers during Ig-immunoadsorption in a patient with newly diagnosed type 1 diabetes. Seidel DK; Geiss HC; Donner MG; Ritter MM; Schwandt P; Koll RA; Standl E; Ziegler AG J Autoimmun; 1998 Jun; 11(3):273-7. PubMed ID: 9693976 [TBL] [Abstract][Full Text] [Related]
8. [Latent autoimmune diabetes in adults(LADA): part of the clinical spectrum of type-1 diabetes mellitus of autoimmune origin]. Pánczél P; Hosszúfalusi N; Bornemisza B; Horváth L; Jánoskuti L; Füst G; Rajczy K; Vatay A; Prohászka Z; Madácsy L; Luczay A; Blatniczky L; Halmos T; Körner A; Szilvási I; Romics L Orv Hetil; 2001 Nov; 142(46):2571-8. PubMed ID: 11770176 [TBL] [Abstract][Full Text] [Related]
9. Developments in the prediction of type 1 diabetes mellitus, with special reference to insulin autoantibodies. Franke B; Galloway TS; Wilkin TJ Diabetes Metab Res Rev; 2005; 21(5):395-415. PubMed ID: 15895384 [TBL] [Abstract][Full Text] [Related]
10. Islet cell antibodies and diabetes in Nigerians. Oli JM; Bottazzo GF; Doniach D Trop Geogr Med; 1981 Jun; 33(2):161-4. PubMed ID: 7025394 [TBL] [Abstract][Full Text] [Related]
11. [Islet cell antibodies in diabetic patients with other autoimmune diseases (author's transl)]. Pujol-Borrell R; Richart C; Marti S; Gomez JM Nouv Presse Med; 1981 Sep; 10(34):2791-3. PubMed ID: 7031598 [TBL] [Abstract][Full Text] [Related]
12. Heterogeneity of islet cell cytoplasmic antibodies and autoantibodies to glutamate decarboxylase in relatives of patients with type 1 (insulin-dependent) diabetes. Bergerot I; Souchier C; Thivolet C C R Acad Sci III; 1993 Nov; 316(11):1368-73. PubMed ID: 8087616 [TBL] [Abstract][Full Text] [Related]
13. Cytotoxic activity of sera from diabetic BB rats against BB rat islet--a functional study. Ziegler B; Klöting I; Besch W; Ziegler M; Hahn HJ Diabetes Res; 1987 Feb; 4(2):67-72. PubMed ID: 3555954 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of insulin release in vitro mediated by mononuclear cells from diabetic patients treated with cyclosporin A or placebo. Debray-Sachs M; Sai P; Feutren G; Lang F; Maugendre D; Boitard C; Hors J; Bach JF Diabetes; 1988 Jul; 37(7):873-7. PubMed ID: 3290005 [TBL] [Abstract][Full Text] [Related]
15. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children. Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086 [TBL] [Abstract][Full Text] [Related]
16. Poor beta-cell function after the clinical manifestation of type 1 diabetes in children initially positive for islet cell specific autoantibodies. The Childhood Diabetes in Finland Study Group. Komulainen J; Knip M; Lounamaa R; Vähäsalo P; Karjalainen J; Sabbah E; Akerblom HK Diabet Med; 1997 Jul; 14(7):532-7. PubMed ID: 9223390 [TBL] [Abstract][Full Text] [Related]
18. Detection of islet cell surface antibodies using cloned beta cells and comparison of their incidence with that of islet cell cytoplasmic antibodies. Grant AM; Harrison DE; Moysey L; Smith D; Ashcroft SJ Diabetes Res; 1985 Sep; 2(5):225-9. PubMed ID: 3905186 [TBL] [Abstract][Full Text] [Related]
19. Biological activity of pig islet-cell reactive IgG antibodies in xenotransplanted diabetic patients. Lindeborg E; Kumagai-Braesch M; Tibell A; Christensson B; Möller E Xenotransplantation; 2004 Sep; 11(5):457-70. PubMed ID: 15303983 [TBL] [Abstract][Full Text] [Related]
20. Antibody-dependent cell-mediated cytotoxicity of mononuclear cells against Langerhans islets of Wistar rats in normal man and in patients at diabetes risk. Köhler E; Knospe S; Woltanski G; Maciejewski R; Salzsieder C; Rjasanowski I; Strese J; Michaelis D Biomed Biochim Acta; 1984; 43(5):627-33. PubMed ID: 6383366 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]